Pre-Transplant MRD Negativity Predicts Favorable Outcomes of CAR-T Therapy for Pediatirc Relapsed and Refractory Acute Lymphoblastic Leukemia Followed By TCR Αβ-Depleted Haplo-HSCT

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Huaying Liu, JingZhihaoSimengYuelinChunfu WangTangLvHeLi

DOI: 10.1016/j.jtct.2025.12.052

Cited by: 1

Fields of Study & Subjects

Acute Lymphoblastic Leukemia research CAR-T cell therapy research Renal and related cancers